Additional Details
-
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Clinical Site PartnersWinter Park FL. 32789View Details -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Renstar Medical ResearchOcala FL. 34470View Details -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Southeastern Research CenterWinston-Salem NC. 27103View Details -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Lowcountry Lung and Critical CareCharleston SC. 29406View Details -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Newport Native MD, Inc.Newport Beach CA. 92663View Details -
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis
Clinical Site Partners, LCCLeesburg FL. 34748View Details -
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
NIEHS Clinical Research Unit (CRU)Research Triangle Park NC. 27709View Details -
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
University of VirginiaCharlottesville VA. 22908View Details -
Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect
University of MichiganAnn Arbor MI. 48109View Details -
Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect
University of VirginiaCharlottesville VA. 22908View Details -
Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect
Massachusetts General HospitalBoston MA. 02114View Details -
Move With Air: Physiological Response Assessment
Centre of Innovative Medicine of the McGill University Health CentreMontreal QC. H4A 3J1View Details -
Move With Air: Exercise Training Study
Centre of Innovative Medicine of the McGill University Health CentreMontreal QC. H4A 3J1View Details -
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Temple UniversityPhiladelphia PA. 19140View Details -
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
UCLA Health Westwood Medical PlazaWestwood CA. 90095View Details -
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
CIC Mauricie Inc.Trois-Rivières QC. G8T 7A1View Details -
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
IUCPQ (Laval University)Québec G1V 4G5View Details -
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Georgetown UniversityWashington D.C. DC. 20007View Details -
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Cleveland ClinicCleveland OH. 44195View Details -
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Royal University Hospital (Saskatoon)Saskatoon SK. S7N 0W8View Details
